A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safetyof Intravenously Administered BIIB092 in Participants with Progressive Supranuclear Palsy

Project: Research project

Description

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BIIB092 in Participants with Progressive Supranuclear Palsy
StatusActive
Effective start/end date4/1/183/31/20

Funding

  • Biogen IDEC

Fingerprint

Progressive Supranuclear Palsy
Placebos
Safety